AMP plans name change to AMP Alternative Medical Products

Home / Press Release  / AMP plans name change to AMP Alternative Medical Products

ERFURT/BERLIN, Germany, January 11th, 2021 – AMP German Cannabis Group Inc. (“AMP” and or “the Company”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces its intention to change its corporate name to AMP Alternative Medical Products Inc. The new corporate name aligns with AMP’s brand name and logo for medical and wellness cannabis products, which AMP will be launching for sale in Germany this quarter.

The Company’s trading symbol on the Canadian Securities Exchange will not change. The Company will announce the new CUSIP and ISIN numbers and, if required, a new Frankfurt Stock Exchange trading symbol when the name change becomes effective.

About AMP German Cannabis Group

AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP sources, stores, transports, delivers, and sells medical cannabis products to pharmaceutical distributors or pharmacists directly, the only point-of-sale for medical cannabis to German patients with a physician’s prescription. AMP has entered into a non-exclusive distribution agreement for medical cannabis with a leading distributor of pharmaceuticals products to more than 13,000 pharmacies throughout Germany.

AMP has sponsored a six-episode roundtable discussion series about medical cannabis in Germany. The Roundtable Series is available by podcast or video. In Episode #2 titled, “Politics and Medical Cannabis in Germany”, Dr. Wieland Schinnenburg, MdB (FDP) provides an up-to-date overview of the political issues and challenges facing the medical cannabis industry in Germany. The panel also includes Dr. Stefan Feuerstein, President of AMP and Mr. Holger Scholze as moderator. AMP Roundtable Series: